SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-14-066051
Filing Date
2014-02-25
Accepted
2014-02-25 07:01:59
Documents
13
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d638779d10k.htm 10-K 1232905
2 EX-10.52 d638779dex1052.htm EX-10.52 23996
3 EX-23.1 d638779dex231.htm EX-23.1 1620
4 EX-31.1 d638779dex311.htm EX-31.1 9977
5 EX-31.2 d638779dex312.htm EX-31.2 9988
6 EX-32.1 d638779dex321.htm EX-32.1 5173
13 GRAPHIC g638779g52s00.jpg GRAPHIC 59239
  Complete submission text file 0001193125-14-066051.txt   8085677

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT vnda-20131231.xml EX-101.INS 1114113
8 XBRL TAXONOMY EXTENSION SCHEMA vnda-20131231.xsd EX-101.SCH 77947
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnda-20131231_cal.xml EX-101.CAL 90294
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnda-20131231_def.xml EX-101.DEF 424940
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnda-20131231_lab.xml EX-101.LAB 541486
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnda-20131231_pre.xml EX-101.PRE 509916
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34186 | Film No.: 14638838
SIC: 2834 Pharmaceutical Preparations